1020725

RXQ Compounding LLC — FEI 3011509553

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 8, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Albany, OH (United States)

Citations

IDCFRDescription
113621 CFR 211.25(c)Inadequate number of personnel
135821 CFR 211.100(b)SOPs not followed / documented
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
143521 CFR 211.42(c)(10)(v)Cleaning System
144821 CFR 211.111Establishment of time limitations
145121 CFR 211.113(b)Procedures for sterile drug products
188321 CFR 211.165(a)Testing and release for distribution
201221 CFR 211.188(b)Batch production and Batch Control Record Requirements
202721 CFR 211.192Investigations of discrepancies, failures